Provided by Tiger Fintech (Singapore) Pte. Ltd.

PMGC Holdings

1.89
-0.0250-1.31%
Post-market: 1.940.0550+2.92%19:59 EDT
Volume:11.61K
Turnover:22.13K
Market Cap:2.59M
PE:-0.06
High:1.93
Open:1.91
Low:1.88
Close:1.91
52wk High:546.00
52wk Low:1.81
Shares:1.38M
Float Shares:1.26M
Volume Ratio:0.27
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-30.3620
EPS(LYR):-78.4818
ROE:-95.21%
ROA:-36.92%
PB:0.32
PE(LYR):-0.02

Loading ...

PMGC Holdings Inc trading halted, volatility trading pause

TIPRANKS
·
Mar 10

Is PMGC Holdings (NASDAQ:ELAB) In A Good Position To Deliver On Growth Plans?

Simply Wall St.
·
Mar 10

Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1

GlobeNewswire
·
Mar 10

PMGC Holdings Inc trading halted, news pending

TIPRANKS
·
Mar 08

PMGC to Implement 1-for-7 Reverse Stock Split; Shares Fall

MT Newswires Live
·
Mar 06

BUZZ-Elevai Labs sinks after announcement of reverse stock split

Reuters
·
Mar 06

BRIEF-PMGC Holdings Announces Reverse Stock Split To Maintain Nasdaq Listing Compliance

Reuters
·
Mar 06

PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

GlobeNewswire
·
Mar 06

BRIEF-Pmgc Holdings Inc And Inmune Bio Terminate License Agreement

Reuters
·
Mar 04

ELEVAI Labs Inc. Ends License Agreement with INmune

TIPRANKS
·
Mar 04

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group

GlobeNewswire
·
Feb 27

PMGC highlights ‘strong’ capital position

TIPRANKS
·
Feb 26

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

GlobeNewswire
·
Feb 26

Northstrive Biosciences Submits Pre-IND Request for EL-22

TIPRANKS
·
Feb 20

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists

GlobeNewswire
·
Feb 18

PMGC files to sell 969,386 shares of common stock for holders

TIPRANKS
·
Feb 12

Northstrive Biosciences Unveils Innovative Obesity Drug Candidates

TIPRANKS
·
Feb 08